blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1800673

EP1800673 - Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.02.2009
Database last updated on 03.09.2024
Most recent event   Tooltip06.02.2009Application deemed to be withdrawnpublished on 11.03.2009  [2009/11]
Applicant(s)For all designated states
Canadian Blood Services
1800 Alta Vista Drive
Ottawa, Ontario K1G 4J5 / CA
[2007/26]
Inventor(s)01 / Branch, Donald R., c/o Canadian Blood Services
67 College Street, Toronto
Ontario M5G 2M1 / CA
02 / Lazarus, Alan H., c/o St. Michael's Hospital
Shuter Wing, 2-001A, 30 Bond Street
Toronto, Ontario M5B 1W8 / CA
03 / Crow, Andrew R.
c/o St. Michael's Hospital Transfusion Medicine Research RM 2-001 S 30Bond Street
Toronto, ON, M5B 1W8 / CA
 [2007/51]
Former [2007/26]01 / Branch, Donald R., c/o Canadian Blood Services
67 College Street, Toronto
Ontario M5G 2M1 / CA
02 / Lazarus, Alan H., c/o St. Michael's Hospital
Shuter Wing, 2-001A, 30 Bond Street
Toronto, Ontario M5B 1W8 / CA
03 / Crow, Andrew, c/o Canadian Blood Services
1800 Alta Vista Drive
Ottawa, Ontario K1G 4J5 / CA
Representative(s)Kuhnen & Wacker Patent- und Rechtsanwaltsbüro PartG mbB
Prinz-Ludwig-Straße 40A
85354 Freising / DE
[N/P]
Former [2007/26]Kuhnen & Wacker
Patent- und Rechtsanwaltsbüro Prinz-Ludwig-Strasse 40A
85354 Freising / DE
Application number, filing date06026477.720.12.2006
[2007/26]
Priority number, dateUS20050752912P23.12.2005         Original published format: US 752912 P
[2007/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1800673
Date:27.06.2007
Language:EN
[2007/26]
Type: A3 Search report 
No.:EP1800673
Date:15.08.2007
[2007/33]
Search report(s)(Supplementary) European search report - dispatched on:EP18.07.2007
ClassificationIPC:A61K31/045, A61K31/105, A61K31/305, C07K16/00, A61P7/06, A61P37/00, A61P19/02, A61P21/04
[2007/26]
CPC:
A61K31/105 (EP,US); A61K31/04 (EP,US); A61K31/045 (EP,US);
A61K31/06 (EP,US); A61K31/305 (EP,US); A61K38/39 (EP,US);
A61K39/395 (EP,US); A61K45/06 (EP,US); A61P19/02 (EP);
A61P21/04 (EP); A61P37/00 (EP); A61P7/06 (EP) (-)
C-Set:
A61K31/045, A61K2300/00 (US,EP);
A61K31/04, A61K2300/00 (US,EP);
A61K31/06, A61K2300/00 (EP,US);
A61K31/105, A61K2300/00 (US,EP);
A61K31/305, A61K2300/00 (US,EP);
A61K38/39, A61K2300/00 (EP,US);
A61K39/395, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/26]
TitleGerman:Nitrophenyle und verwandte Zusammensetzungen sowie Thimerosal zur Hemmung von immunspezifischer Zell- oder Gewebezerstörung[2007/26]
English:Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction[2007/26]
French:Nitrophényles et composés associés et thimérosal pour l'inhibition de la destruction cellulaire ou tissulaire liée à l'immunité[2007/26]
Examination procedure16.01.2008Examination requested  [2008/09]
11.04.2008Despatch of a communication from the examining division (Time limit: M04)
22.08.2008Application deemed to be withdrawn, date of legal effect  [2009/11]
30.09.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/11]
Fees paidPenalty fee
Additional fee for renewal fee
31.12.200803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9412163  (ABBOTT LAB [US]) [X] 1,2,7 * page 4, line 20 - page 5, line 16 * * page 8, line 12 - page 10, line 36 * * claims 1,3,4 *;
 [X]EP1232748  (MEN TEWA [CN], et al) [X] 1,6-8,18,19,21 * column 1, paragraphs 4-6 * * columns 3-4, paragraph 21 * * column 5, paragraphs 26,27 * * column 6, line 56 - column 7, line 4 * * column 8, paragraphs 31,35 * * column 12, lines 50,51 * * column 12, paragraph 49 - column 13, paragraph 50 * * column 17, lines 7-15 * * column 17, line 46 - column 18, line 3 * * claims 1,6,9,13 *;
 [X]WO9925347  (NEUROSEARCH AS [DK], et al) [X] 1,6-8,18-21 * page 5, lines 1-5 * * page 7, lines 7-30 * * page 9, line 21 - page 10, line 4 * * page 20, line 6 - page 21, line 8 * * claims 1,13,16 *;
 [X]WO0135955  ;
 [X]EP1247818  (ORTHO CLINICAL DIAGNOSTICS INC [US]) [X] 11,17 * page 4, paragraphs 16,17 * * claims 1,3,6-8 *;
 [X]GB1546177  (BIOKEMA SA) [X] 11,17 * page 1, lines 9-15 * * page 2, lines 18-24 * * claims 1,7,10,17 *;
 [X]WO0162668  (UNIV HEALTH NETWORK [CA], et al) [X] 9 * page 1, lines 8-13 * * page 5, lines 20-38 * * page 7, line 30 * * page 13, line 17 - page 14, line 3 * * page 63, lines 9-13 * * claim 19 *;
 [X]US2003144286  (FRENKEL ALEXANDER DAVID [GB], et al) [X] 18-20 * figures 1a,1c,1d,1e,2a,2b,3a,3b * * page 1, paragraph 7 * * page 11, paragraph 123 * * page 14, paragraph 155 - page 15, paragraph 156 * * examples 1-7,15-17,19,21,28,30 * * claims 54,62,66,67 *;
 [X]WO9731016  (ARIAD PHARMA INC [US]) [X] 18 * page 2, lines 10-19 * * page 5, lines 6-15 * * page 9, lines 19-21 * * page 9, line 32 - page 10, line 16 *;
 [X]JP2004018465  ;
 [X]WO2005013947  (UNIVERSITAETSKLINIKUM MUENSTER [DE], et al) [X] 18,19 * page 1, lines 11-16 * * page 32, line 26 - page 33, line 24 * * page 70, line 28 - page 71, line 20 * * claims 1,7,8,10 *;
 [X]WO2005117949  (ARES TRADING SA [CH], et al) [X] 18,20 * page 4, lines 1-10 * * page 14, lines 29-34 * * claims 1,25,31 *;
 [A]JPS6191382  ;
 [DX]  - RAMPERSAD GREGORY C ET AL, "Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells", TRANSFUSION (MALDEN), (200503), vol. 45, no. 3, ISSN 0041-1132, pages 384 - 393, XP002428390 [DX] 1,3,5,8,9,11-13,15,17 * abstract * * page 384, column 2, paragraph 1 - page 385, column 1, paragraph 1 * * page 385, column 1, paragraph 4 * * page 385, column 2, paragraph 3 * * figures 1,2,4 * * page 387, column 2, paragraph 2 * * page 388, column 2, paragraph 2 * * page 390, column 2, paragraph 2 - page 391, column 2, paragraph L *

DOI:   http://dx.doi.org/10.1111/j.1537-2995.2005.04241.x
 [X]  - BRANCH DONALD R ET AL, "Targeted Interference of Monocyte-Macrophage Membrane Disulfide and Thiol Groups Results in Inhibition of Fc-Receptor Mediated Phagaocytosis of Antibody-Coated Red Cells.", BLOOD, & 44TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; PHILADELPHIA, PA, USA; DECEMBER 06-10, 2002, (20021116), vol. 100, no. 11, ISSN 0006-4971, page Abstract No. 1084, XP008077342 [X] 5-8,11,17 * the whole document *
 [X]  - ADACHI Y. ET AL., "Benzene derivatives and use thereof as drugs", DATABASE WPI, 0, Derwent World Patents Index, (20010525), no. 20, Database accession no. 2001389812, page 1, XP002428401 & WO0135955 A 20010525 (TORAY IND INC) [X] 1,2,7 * column A *
 [X]  - MENG CHARLES Q ET AL, "Nitrobenzene compounds inhibit expression of VCAM-1", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (20010723), vol. 11, no. 14, ISSN 0960-894X, pages 1823 - 1827, XP008080765 [X] 18 * abstract * * table 1 * * page 1824, column 2, paragraph 1 - page 1825, column 2, paragraph 1 * * figures 1-5 * * page 1826, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(01)00306-7
 [X]  - KATO F. ET AL., "Cytokine production depressant characterised by selectively controlling IL-5 production", DATABASE WPI, 0, Derwent World Patents Index, (20040122), no. 20, Database accession no. 2004-195480, page 9, XP002441612 & JP2004018465 A 20040122 (ISHIHARA SANGYO KAISHA LTD) [X] 18 * the whole document *
 [A]  - MURAKAMI ET AL., "Manufacture of 2-(nitrophenyl)ethanols", DATABASE WPI, 0, Derwent World Patents Index, (19860509), no. 19, Database accession no. 1986-158941, page 5, XP002428402 & JPS6191382 A 19860509 (NIPPON KAYAKU KK) [A] 10 * column A *
 [A]  - HOLDER JAMES W, "Nitrobenzene carcinogenicity in animals and human hazard evaluation", TOXICOLOGY AND INDUSTRIAL HEALTH, (199908), vol. 15, no. 5, ISSN 0748-2337, pages 445 - 457, XP008077336 [A] 1 * abstract * * page 453, column 1, paragraph 3 - column 2, paragraph 1 * * page 454, column 2, paragraph 1 *
 [A]  - NISTOR CATALIN ET AL, "Competitive flow immunoassay with fluorescence detection for determination of 4-nitrophenol", ANALYTICA CHIMICA ACTA, (20010112), vol. 426, no. 2, ISSN 0003-2670, pages 185 - 195, XP002428391 [A] 1,2 * abstract * * page 185, column 2, paragraph 1 - page 186, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0003-2670(00)00825-4
 [A]  - TSAI W-M ET AL, "INFLUENCE OF FREE THIOL GROUPS ON AUTOANTIBODY-DEFINED EPITOPE OF PROLIFERATING CELL NUCLEAR ANTIGEN", JOURNAL OF IMMUNOLOGY, (1992), vol. 149, no. 6, ISSN 0022-1767, pages 2227 - 2233, XP002441531 [A] 18 * abstract *
 [DPX]  - FOO ALISON H ET AL, "Structure-function studies for in vitro chemical inhibition of Fc gamma receptor-mediated phagocytosis.", TRANSFUSION FEB 2007, (200702), vol. 47, no. 2, ISSN 0041-1132, pages 290 - 298, XP002428392 [DPX] 1-4,6-10 * abstract * * page 291, column 1, paragraph 2 * * figures 1-3 * * page 293, column 1, paragraph 2 - page 296, column 1, paragraph 1 * * page 296, column 2, paragraph L - page 297, column 1, paragraph L *

DOI:   http://dx.doi.org/10.1111/j.1537-2995.2007.01105.x
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.